Breaking News Instant updates and real-time market news.

2021-03-16 11:18:28 PLMI Plum Acquisition Corp. I $0.00 / + (+0.00%) 11:18 03/16/21 03/16 11:18 03/16/21 11:18	Plum Acquisition Corp. I opens at $9.99, IPO priced at $10 Plum Acquisition Corp. I, a newly incorporated special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, priced its initial public offering of 30M units at $10.00 per unit. The units are listed on the Nasdaq and trade under the ticker symbol "PLMI U". Once the securities comprising the units begin separate trading, the company expects that the class A ordinary shares and redeemable warrants will be listed on Nasdaq under the symbols "PLMI" and "PLMI W," respectively. Plum Acquisition Corp. I currently intends to pursue opportunities with internet and software companies "that leverage platform models in enterprise software, SMB software and infrastructure, or disruptive marketplace models in verticals where the Plum team has extensive expertise, such as business automation, health and wellbeing, and finance- and insurance-related tech." Goldman Sachs is serving as sole book-running manager for the offering.

2021-03-16 11:18:28

PLMI

Plum Acquisition Corp. I

$0.00 / + (+0.00%)

11:18

03/16/21

03/16

11:18

03/16/21

11:18

Plum Acquisition Corp. I opens at $9.99, IPO priced at $10

Plum Acquisition Corp. I, a newly incorporated special purpose acquisition company formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses, priced its initial public offering of 30M units at $10.00 per unit. The units are listed on the Nasdaq and trade under the ticker symbol "PLMI U". Once the securities comprising the units begin separate trading, the company expects that the class A ordinary shares and redeemable warrants will be listed on Nasdaq under the symbols "PLMI" and "PLMI W," respectively. Plum Acquisition Corp. I currently intends to pursue opportunities with internet and software companies "that leverage platform models in enterprise software, SMB software and infrastructure, or disruptive marketplace models in verticals where the Plum team has extensive expertise, such as business automation, health and wellbeing, and finance- and insurance-related tech." Goldman Sachs is serving as sole book-running manager for the offering.

OTHER BREAKING NEWS FROM THE FLY

Hot Stocks	News Corp trading halted, volatility trading pause 09:30 08/09/22 08/09 09:30 08/09/22 09:30 NWS News Corp. $17.57 / +0.375 (+2.18%) ShowHide Related Items >><< Company News Street Research Earnings Periodicals Events NWS News Corp. $17.57 / +0.375 (+2.18%) 05/11/22 Realtor.com Seller's Marketplace adds four new selling options 02/28/22 News Corp. completes acquisition of OPIS for $1.15B in cash NWS News Corp. $17.57 / +0.375 (+2.18%) 07/10/22 Goldman Sachs News Corp. downgraded to Buy from Conviction Buy at Goldman Sachs NWS News Corp. $17.57 / +0.375 (+2.18%) 08/08/22 News Corp. reports Q4 adjusted EPS 37c, consensus 7c 05/05/22 News Corp. reports Q3 adjusted EPS 16c, consensus 14c NWS News Corp. $17.57 / +0.375 (+2.18%) 06/22/22 Rupert Murdoch, Jerry Hall are getting a divorce, NY Times reports 04/20/22 News Corp. to help launch online betting brand in Australia, WSJ reports 17:00 Today News Corp. - NWS
Recommendations	Ramaco Resources price target lowered to $14 from $18 at BMO Capital » 09:30 08/09/22 08/09 09:30 08/09/22 09:30 METC Ramaco Resources $11.20 / +0.045 (+0.40%) BMO Capital analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events METC Ramaco Resources $11.20 / +0.045 (+0.40%) 08/08/22 Ramaco Resources sees FY22 CapEx $105M-$125M 08/08/22 Ramaco Resources to acquire Maben Coal for $30M 07/14/22 Ramaco Resources announces $5M Q3 cash dividend 07/11/22 Ramaco Resources experiences methane ignition at Berwind Complex METC Ramaco Resources $11.20 / +0.045 (+0.40%) 06/07/22 Jefferies Ramaco Resources upgraded to Buy from Hold at Jefferies 03/09/22 Jefferies Ramaco Resources price target raised to $19 from $16 at Jefferies 03/08/22 B. Riley Ramaco Resources price target raised to $31 from $22 at B. Riley 02/03/22 B. Riley Ramaco Resources price target raised to $22 from $20 at B. Riley METC Ramaco Resources $11.20 / +0.045 (+0.40%) 08/08/22 Ramaco Resources reports Q2 EPS 74c, consensus $1.49 05/11/22 Ramaco Resources reports Q1 EPS 92c, consensus $1.62 02/24/22 Ramaco Resources reports Q4 EPS 42c, consensus 41c 09:00 Today Ramaco Resources - METC
Recommendations	eHealth price target lowered to $8 from $12 at Truist » 09:28 08/09/22 08/09 09:28 08/09/22 09:28 EHTH eHealth $8.29 / +0.52 (+6.69%) Truist analyst Tobey… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly EHTH eHealth $8.29 / +0.52 (+6.69%) 03/01/22 eHealth sinks 22% to $12.05 after Q4 results miss estimates 03/01/22 eHealth CEO 'implementing a number of changes' 03/01/22 eHealth plans 'multi-year transformation initiative' 02/28/22 eHealth appoints Roman Rariy as COO, CTO EHTH eHealth $8.29 / +0.52 (+6.69%) 05:35 Today Citi eHealth price target lowered to $9 from $13 at Citi 05/05/22 Deutsche Bank eHealth price target lowered to $10 from $19 at Deutsche Bank 03/31/22 Credit Suisse eHealth assumed with a Neutral at Credit Suisse 03/21/22 Citi eHealth downgraded to Neutral from Buy at Citi EHTH eHealth $8.29 / +0.52 (+6.69%) 08/08/22 eHealth reports Q2 adjusted EPS ($1.15), consensus ($1.15) 08/08/22 eHealth cuts FY revenue view to $375M-$395M from $448M-$470M 05/03/22 eHealth sees FY22 revenue $448M-$470M, consensus $456.6M 05/03/22 eHealth reports Q1 adjusted EPS (91c), consensus ($1.19) EHTH eHealth $8.29 / +0.52 (+6.69%) 03/21/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Syndicate	Aytu BioPharma 21.5M share Spot Secondary priced at 43c » 09:27 08/09/22 08/09 09:27 08/09/22 09:27 AYTU Aytu BioPharma / + Cantor Fitzgerald and… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events AYTU Aytu BioPharma / + 09:18 Today Aytu BioPharma announces pricing of public offering 07/20/22 Aytu BioPharma initiates AR101 Phase 3 PREVEnt trial 04/19/22 Aytu BioScience announces Fast Track designation for AR101 03/23/22 Aytu BioScience announces newly issued patent from Cotempla XR-ODT AYTU Aytu BioPharma / + 07/21/22 H.C. Wainwright Aytu BioPharma price target lowered to $6 from $11 at H.C. Wainwright 05/17/22 Cantor Fitzgerald Aytu BioPharma price target lowered to $5 from $11 at Cantor Fitzgerald 04/28/22 H.C. Wainwright Aytu BioScience price target lowered to $11 from $24 at H.C. Wainwright 09 Aug 08/08/22 42nd Annual Global I Growth Conference
Syndicate	Medicenna Therapeutics 13.333M share Spot Secondary priced at $1.50 » 09:25 08/09/22 08/09 09:25 08/09/22 09:25 MDNA Medicenna Therapeutics $1.77 / +0.04 (+2.31%) The deal range was… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate MDNA Medicenna Therapeutics $1.77 / +0.04 (+2.31%) 09:17 Today Medicenna Therapeutics announces pricing of $20M public offering 07/27/22 Medicenna announces clinical data from Phase 1/2 ABILITY study of MDNA11 06/22/22 Medicenna Therapeutics sees cash runway late into 2Q23 06/22/22 Medicenna Therapeutics announces expected upcoming milestones MDNA Medicenna Therapeutics $1.77 / +0.04 (+2.31%) 06/22/22 Oppenheimer Medicenna Therapeutics price target lowered to $10 from $12 at Oppenheimer 03/15/22 H.C. Wainwright Nektar failure has no read-through for Medicenna, says H.C. Wainwright 12/22/21 Oppenheimer Medicenna preliminary MDNA11 data 'impressive,' says Oppenheimer MDNA Medicenna Therapeutics $1.77 / +0.04 (+2.31%) 06/22/22 Medicenna Therapeutics reports 2022 EPS (42c) vs. (35c) last year 09 Aug
Initiation	Coupang initiated with an Outperform at Macquarie » 09:24 08/09/22 08/09 09:24 08/09/22 09:24 CPNG Coupang $19.20 / -0.04 (-0.21%) Macquarie analyst Danny… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options CPNG Coupang $19.20 / -0.04 (-0.21%) 07/15/22 Coupang rises 7.9% 07/01/22 Coupang rises 13.4% 07/01/22 Coupang rises 9.1% 05/12/22 Coupang rises 24.8% CPNG Coupang $19.20 / -0.04 (-0.21%) 06/30/22 Credit Suisse Coupang upgraded to Outperform at Credit Suisse following underperformance 06/30/22 Credit Suisse Coupang upgraded to Outperform from Neutral at Credit Suisse 06/29/22 Morgan Stanley Coupang initiated with an Overweight at Morgan Stanley 05/12/22 Mizuho Coupang price target lowered to $18 from $28 at Mizuho CPNG Coupang $19.20 / -0.04 (-0.21%) 05/11/22 Coupang reports Q1 EPS (12c), consensus (17c) 03/02/22 Coupang sees 2022 adjusted EBITDA loss less than ($400M) 03/02/22 Coupang reports Q4 EPS (23c), consensus (19c) 14 Sep CPNG Coupang $19.20 / -0.04 (-0.21%) 03/28/22 Softbank's Alibaba shares in spotlight amid stock turbulence, WSJ reports CPNG Coupang $19.20 / -0.04 (-0.21%) 07/01/22 What You Missed On Wall Street On Friday 07/01/22 What You Missed On Wall Street This Morning 07/01/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 07/01/22 Fly Intel: Pre-market Movers 08/10/22 Coupang - CPNG CPNG Coupang $19.20 / -0.04 (-0.21%) 07/20/22 Unusually active option classes on open July 20th 07/01/22 Coupang call volume above normal and directionally bullish 06/17/22 Coupang call volume above normal and directionally bullish 05/31/22 Unusually active option classes on open May 31st
Recommendations	Nvidia price target lowered to $216 from $283 at Truist » 09:23 08/09/22 08/09 09:23 08/09/22 09:23 NVDA Nvidia $177.97 / -11.97 (-6.30%) Truist analyst William… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NVDA Nvidia $177.97 / -11.97 (-6.30%) 08/08/22 Cathie Wood's ARK Investment bought 360K shares of Nvidia today 08/08/22 Nvidia falls 6.9% to $176.74 after negative Q2 revenue pre-announcement 07/20/22 Motorsport Games brings two titles to NVIDIA GeForce NOWNvidia 07/15/22 U.S. video game spending falls 11% y/y in June, says NPD NVDA Nvidia $177.97 / -11.97 (-6.30%) 07:07 Today Susquehanna Nvidia price target lowered to $210 from $220 at Susquehanna 06:41 Today Mizuho Nvidia price target lowered to $250 from $290 at Mizuho 08/08/22 Summit Insights Nvidia underestimated its exposure to crypto mining, says Summit Insights 08/08/22 Oppenheimer Nvidia price target lowered to $250 from $300 at Oppenheimer NVDA Nvidia $177.97 / -11.97 (-6.30%) 08/08/22 Nvidia reports preliminary Q2 revenue $6.7B, consensus $8.1B 05/25/22 Nvidia sees Q2 revenue $8.1B, +/- 2%, consensus $8.45B 05/25/22 Nvidia reports Q1 EPS $1.36, consensus $1.29 05/25/22 Notable companies reporting after market close NVDA Nvidia $177.97 / -11.97 (-6.30%) 07/28/22 House passes bill giving $52B to U.S. chipmakers, Bloomberg reports 07/28/22 Pelosi's husband sells Nvidia shares as House weighs chip bill, Reuters says 07/27/22 Senate pushes bipartisan chip bill to House to boost U.S, production, CNN says 07/19/22 New bill to provide $52B boost to US semiconductor manufacturing, WSJ reports NVDA Nvidia $177.97 / -11.97 (-6.30%) 08/08/22 What You Missed On Wall Street On Monday 08/08/22 What You Missed On Wall Street This Morning 08/05/22 Here's What You Missed in Crypto This Week 07/29/22 Here's What You Missed in Crypto This Week 08/24/22 Nvidia - NVDA NVDA Nvidia $177.97 / -11.97 (-6.30%) 08:55 Today Notable open interest changes for August 9th 07/21/22 NVIDIA call buyer realizes 58% same-day gains 06/21/22 Early notable gainers among liquid option names on June 21st 06/17/22 Notable open interest changes for June 17th
Hot Stocks	WISeKey implementing post-quantum algorithms » 09:22 08/09/22 08/09 09:22 08/09/22 09:22 WKEY WISeKey $2.66 / +0.03 (+1.14%) During the last two… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research WKEY WISeKey $2.66 / +0.03 (+1.14%) 07/26/22 WISeKey launches WISe.ART Metaverse NFT Factory 07/25/22 WISeKey to NFT art piece by Picasso Art 'The Magic Violin' 07/08/22 WISeKey selected as collaborator by NIST for consortium project 07/06/22 WISeKey, China Museum of Finance extend cooperation for digital museum WKEY WISeKey $2.66 / +0.03 (+1.14%) 05/02/22 H.C. Wainwright WISeKey price target lowered to $4 from $11 at H.C. Wainwright 02/01/22 Maxim WISeKey price target cut to $8 from $11 at Maxim 12/10/21 Maxim WISeKey initiated with a Buy at Maxim
Hot Stocks	Strong Studios to develop, produce film on Joe Moglia » 09:21 08/09/22 08/09 09:21 08/09/22 09:21 BTN Ballantyne Strong $2.65 / -0.02 (-0.75%) Strong Studios, a… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News BTN Ballantyne Strong $2.65 / -0.02 (-0.75%) 07/14/22 Fundamental Global buys additional shares of Ballantyne Strong 06/30/22 Strong Studios, The Cartel start production on Safehaven 04/27/22 STRONG Technical Services partners with GDC Technology 04/26/22 Ballantyne Strong's STRONG/MDI to open new screen finishing facility
Recommendations	Crispr Therapeutics price target raised to $69 from $55 at Stifel » 09:21 08/09/22 08/09 09:21 08/09/22 09:21 CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) Stifel analyst Benjamin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 06/21/22 Crispr Therapeutics down 11% as Virtual Innovation Day continues 06/13/22 Cathie Wood's ARK Investment bought 89K shares of Crispr Therapeutics today 06/12/22 Crispr Therapeutics presents results from Phase 1 COBALT-LYM trial of CTX130 06/12/22 Vertex, Crispr Therapeutics present new data on exa-cel CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 07:20 Today Credit Suisse Crispr Therapeutics price target raised to $90 from $74 at Credit Suisse 05:33 Today Barclays Crispr Therapeutics downgraded to Equal Weight from Overweight at Barclays 08/08/22 Chardan Crispr Therapeutics price target lowered to $154 from $164 at Chardan 08/02/22 Citi Crispr Therapeutics price target raised to $83 from $53 at Citi CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 08/08/22 Crispr Therapeutics reports Q2 EPS ($2.40), consensus ($2.23) 05/09/22 Crispr Therapeutics reports Q1 EPS ($2.32), consensus ($1.94) 02/15/22 Crispr Therapeutics reports Q4 EPS ($1.84), consensus ($1.77) CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 07/25/22 Researchers warn CRISPR gene editing may trigger cancer, Jerusalem Post says CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 06/22/22 What You Missed On Wall Street On Wednesday 06/22/22 What You Missed On Wall Street This Morning 06/17/22 What You Missed On Wall Street On Friday 06/17/22 What You Missed On Wall Street This Morning CRSP Crispr Therapeutics $81.33 / -0.02 (-0.02%) 07/28/22 Crispr Therapeutics options imply 3.9% move in share price post-earnings 05/20/22 Largest borrow rate increases among liquid names 04/26/22 Crispr Therapeutics options imply 5.6% move in share price post-earnings

Recommendations	CarGurus price target lowered to $27 from $32 at Needham » 09:20 08/09/22 08/09 09:20 08/09/22 09:20 CARG CarGurus $25.77 / +0.01 (+0.04%) Needham analyst Chris… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events CARG CarGurus $25.77 / +0.01 (+0.04%) 07/27/22 CarGurus appoints Javier Zamora as general counsel 06/06/22 CarOffer launches PremiumXchange exchange desk 05/11/22 CarGurus announces launch of CarGurus Digital Deal 03/28/22 CarGurus expands CarGurus Instant Max Cash Offer to four more states CARG CarGurus $25.77 / +0.01 (+0.04%) 08:32 Today DA Davidson CarGurus price target lowered to $30 from $34 at DA Davidson 07:53 Today Raymond James CarGurus price target lowered to $28 from $34 at Raymond James 07:37 Today Oppenheimer CarGurus price target lowered to $32 from $38 at Oppenheimer 07:16 Today Truist CarGurus price target lowered to $38 from $44 at Truist CARG CarGurus $25.77 / +0.01 (+0.04%) 08/08/22 CarGurus sees Q3 EPS 25c-28c, consensus 33c 08/08/22 CarGurus reports Q2 EPS 32c, consensus 31c 08/08/22 Notable companies reporting after market close 05/25/22 CarGurus now sees Q2 adjusted EPS 27c-30c vs. prior 26c-29c view CARG CarGurus $25.77 / +0.01 (+0.04%) 08/08/22 Fly Intel: After-Hours Movers 07/25/22 Fly Insider: CrossFirst Bankshares, Canoo among week's notable insider trades 05/10/22 Fly Intel: Pre-market Movers 02/25/22 What You Missed On Wall Street On Friday 09/07/22 CarGurus
Hot Stocks	Aytu BioPharma announces pricing of public offering » 09:18 08/09/22 08/09 09:18 08/09/22 09:18 AYTU Aytu BioPharma / + Aytu BioPharma announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Syndicate Events AYTU Aytu BioPharma / + 07/20/22 Aytu BioPharma initiates AR101 Phase 3 PREVEnt trial 04/19/22 Aytu BioScience announces Fast Track designation for AR101 03/23/22 Aytu BioScience announces newly issued patent from Cotempla XR-ODT 03/02/22 Aytu BioScience granted orphan designation in Europe for AR101 AYTU Aytu BioPharma / + 07/21/22 H.C. Wainwright Aytu BioPharma price target lowered to $6 from $11 at H.C. Wainwright 05/17/22 Cantor Fitzgerald Aytu BioPharma price target lowered to $5 from $11 at Cantor Fitzgerald 04/28/22 H.C. Wainwright Aytu BioScience price target lowered to $11 from $24 at H.C. Wainwright 09 Aug 08/08/22 42nd Annual Global I Growth Conference
Recommendations	Turtle Beach price target lowered to $18 from $32 at Lake Street » 09:18 08/09/22 08/09 09:18 08/09/22 09:18 HEAR Turtle Beach $14.00 / -0.145 (-1.03%) Lake Street analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 08/08/22 Turtle Beach concludes proactive outreach to potential buyers 05/16/22 Turtle Beach reaches board refreshment agreement with Donerail Group 05/15/22 Fly Intel: Top five weekend stock stories 05/10/22 Turtle Beach launches Neat Microphones brand in Europe HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 07:36 Today DA Davidson Turtle Beach downgraded to Neutral from Buy at DA Davidson 07:30 Today Oppenheimer Turtle Beach downgraded to Perform on weaker outlook at Oppenheimer 07:26 Today Wedbush Turtle Beach price target lowered to $12 from $22 at Wedbush 06:38 Today Oppenheimer Turtle Beach downgraded to Perform from Outperform at Oppenheimer HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 08/08/22 Turtle Beach sees FY22 EPS ($1.35) to (90c), consensus 89c 08/08/22 Turtle Beach reports Q2 EPS ($1.08), consensus (38c) 05/04/22 Turtle Beach backs FY22 EPS view 70c-$1.20, consensus 89c 05/04/22 Turtle Beach reports Q1 adjusted EPS (39c), consensus (52c) HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 05/15/22 Gaming gear provider Turtle Beach nears board deal with Donerail, Reuters says 03/22/22 Citron 'pounding table' on Turtle Beach, sees 'imminent' buyout 03/03/22 Citron highlights The Deal report of Turtle Beach weighing options HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 08/08/22 Fly Intel: After-Hours Movers 05/17/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 03/22/22 What You Missed On Wall Street On Tuesday 03/22/22 What You Missed On Wall Street This Morning HEAR Turtle Beach $14.00 / -0.145 (-1.03%) 06/17/22 Turtle Beach call volume above normal and directionally bullish 05/17/22 Unusual call flow in option market yesterday 05/16/22 Calls lead puts 1200 to one in Turtle Beach with focus on 20 strike 05/16/22 Unusually active option classes on open May 16th
Hot Stocks	E2open expands partnership with Shippeo » 09:17 08/09/22 08/09 09:17 08/09/22 09:17 ETWO E2open $7.41 / +0.21 (+2.92%) E2open and Shippeo have… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly ETWO E2open $7.41 / +0.21 (+2.92%) 07/12/22 E2open falls -17.0% 07/12/22 E2open falls -11.6% 07/12/22 E2open falls -7.4% 07/11/22 E2open falls 4.6% to $7.20 after Q1 results and FY23 guidance cut ETWO E2open $7.41 / +0.21 (+2.92%) 04/28/22 Loop Capital E2open price target lowered to $12 from $16 at Loop Capital 04/21/22 BofA E2open upgraded to Buy at BofA on accelerating revenue growth 04/21/22 BofA E2open upgraded to Buy from Neutral at BofA 03/23/22 Colliers E2open upgraded to Buy from Neutral at Colliers ETWO E2open $7.41 / +0.21 (+2.92%) 07/11/22 E2open cuts FY23 revenue view to $672M-$680M from $681M-$689M 07/11/22 E2open reports Q1 adjusted EPS 7c, consensus 5c 07/11/22 Notable companies reporting after market close 04/27/22 E2open sees FY23 revenue $681M-$689M, consensus $640.21M ETWO E2open $7.41 / +0.21 (+2.92%) 07/12/22 What You Missed On Wall Street On Tuesday 07/12/22 What You Missed On Wall Street This Morning 07/11/22 Fly Intel: After-Hours Movers 04/29/22 Proven algorithm says sell these stocks now
Hot Stocks	Medicenna Therapeutics announces pricing of $20M public offering » 09:17 08/09/22 08/09 09:17 08/09/22 09:17 MDNA Medicenna Therapeutics $1.77 / +0.04 (+2.31%) Medicenna Therapeutics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate MDNA Medicenna Therapeutics $1.77 / +0.04 (+2.31%) 07/27/22 Medicenna announces clinical data from Phase 1/2 ABILITY study of MDNA11 06/22/22 Medicenna Therapeutics sees cash runway late into 2Q23 06/22/22 Medicenna Therapeutics announces expected upcoming milestones 06/09/22 Medicenna announces USPTO patent that 'strengthens IP protection' MDNA Medicenna Therapeutics $1.77 / +0.04 (+2.31%) 06/22/22 Oppenheimer Medicenna Therapeutics price target lowered to $10 from $12 at Oppenheimer 03/15/22 H.C. Wainwright Nektar failure has no read-through for Medicenna, says H.C. Wainwright 12/22/21 Oppenheimer Medicenna preliminary MDNA11 data 'impressive,' says Oppenheimer MDNA Medicenna Therapeutics $1.77 / +0.04 (+2.31%) 06/22/22 Medicenna Therapeutics reports 2022 EPS (42c) vs. (35c) last year 09 Aug
Hot Stocks	Ralph Lauren seeing broad based strength across all regions » 09:17 08/09/22 08/09 09:17 08/09/22 09:17 RL Ralph Lauren $101.19 / +0.96 (+0.96%) Says not immune to macro… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events RL Ralph Lauren $101.19 / +0.96 (+0.96%) 06/24/22 Ralph Lauren announces nomination of Cupp to board of directors 06/24/22 Ralph Lauren publishes 2022 Global Citizenship & Sustainability Report 05/24/22 Ralph Lauren expects all 3 regions to drive positive revenue growth this year 05/24/22 Ralph Lauren sees growth in owned and wholesale digital in FY23 RL Ralph Lauren $101.19 / +0.96 (+0.96%) 08/05/22 Credit Suisse Ralph Lauren price target lowered to $120 from $130 at Credit Suisse 08/01/22 Deutsche Bank Ralph Lauren price target lowered to $99 from $101 at Deutsche Bank 07/21/22 Goldman Sachs Ralph Lauren price target lowered to $78 from $85 at Goldman Sachs 07/15/22 UBS Ralph Lauren price target lowered to $129 from $162 at UBS RL Ralph Lauren $101.19 / +0.96 (+0.96%) 08:06 Today Ralph Lauren backs FY23 revenue view up high single digits, consensus $6.38B 08:05 Today Ralph Lauren sees Q2 revenue up 11%, consensus $1.58B 08:04 Today Ralph Lauren reports Q1 adjusted EPS $1.88 vs. $2.29 last year 08/08/22 Notable companies reporting before tomorrow's open RL Ralph Lauren $101.19 / +0.96 (+0.96%) 02/22/22 LVMH held talks in recent years on Ralph Lauren deal potential, Axios says RL Ralph Lauren $101.19 / +0.96 (+0.96%) 05/24/22 What You Missed On Wall Street On Tuesday 05/24/22 What You Missed On Wall Street This Morning 05/23/22 What You Missed On Wall Street On Monday 05/23/22 What You Missed On Wall Street This Morning 09:00 Today Ralph Lauren - RL
Recommendations	SI-Bone price target lowered to $24 from $28 at Needham » 09:16 08/09/22 08/09 09:16 08/09/22 09:16 SIBN SI-Bone $16.52 / -0.21 (-1.26%) Needham analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SIBN SI-Bone $16.52 / -0.21 (-1.26%) 06/13/22 SI-Bone announces FDA clearance for expanded indication of iFuse-TORQ system 05/31/22 SI-Bone receives FDA 510(k) clearance for iFuse Bedrock Granite 04/19/22 SI-Bone announces NTAP for adult spinal deformity treatment SIBN SI-Bone $16.52 / -0.21 (-1.26%) 05/10/22 Canaccord SI-Bone price target lowered to $25 from $32 at Canaccord 04/07/22 Cantor Fitzgerald SI-Bone assumed with an Overweight at Cantor Fitzgerald 12/21/21 Truist SI-Bone price target lowered to $30 from $35 at Truist 11/09/21 Needham SI-Bone price target lowered to $32 from $37 at Needham SIBN SI-Bone $16.52 / -0.21 (-1.26%) 08/08/22 SI-Bone backs FY22 revenue view $106M-$108M, consensus $107.26M 08/08/22 SI-Bone reports Q2 EPS (54c) vs. (42c) last year 05/09/22 SI-Bone backs prior FY22 revenue view $106M-$108M, consensus $107.35M 05/09/22 SI-Bone reports Q1 EPS (52), consensus (43c) 08/08/22 42nd Annual Global I Growth Conference
Hot Stocks	Nova Vision Acquisition announces additional contribution to trust account » 09:16 08/09/22 08/09 09:16 08/09/22 09:16 NOVV Nova Vision Acquisition $10.06 / + (+0.00%) Nova Vision Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Downgrade	Linde downgraded to Reduce from Add at Baader Helvea » 09:15 08/09/22 08/09 09:15 08/09/22 09:15 LIN Linde $301.02 / -0.99 (-0.33%) Baader Helvea analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly LIN Linde $301.02 / -0.99 (-0.33%) 06/12/22 Fly Intel: Top five weekend stock stories 05/17/22 BP, Linde plan major CCS project in Texas 04/28/22 Linde rises after Q1 results prompt FY22 guidance hike 04/13/22 Linde to double merchant liquid production capacity at Texas facility LIN Linde $301.02 / -0.99 (-0.33%) 08/02/22 Deutsche Bank Linde price target lowered to EUR 350 from EUR 352 at Deutsche Bank 07/29/22 Deutsche Bank Linde price target lowered to $355 from $370 at Deutsche Bank 07/29/22 JPMorgan Linde price target lowered to $350 from $360 at JPMorgan 07/13/22 BofA Linde price target lowered to $369 from $370 at BofA LIN Linde $301.02 / -0.99 (-0.33%) 02/10/22 Linde sees FY22 adjusted EPS $11.55-$11.85, consensus $10.30 02/10/22 Linde sees Q1 adjusted EPS $2.70-$2.80, one estimate $2.46 02/10/22 Linde reports Q4 adjusted EPS $2.77, consensus $2.36 LIN Linde $301.02 / -0.99 (-0.33%) 06/11/22 Linde is steady in a volatile market, also scores high on ESG, Barron's says LIN Linde $301.02 / -0.99 (-0.33%) 05/31/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations
Recommendations	DermTech price target lowered to $14 from $34 at Lake Street » 09:15 08/09/22 08/09 09:15 08/09/22 09:15 DMTK DermTech $8.42 / -0.02 (-0.24%) Lake Street analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly DMTK DermTech $8.42 / -0.02 (-0.24%) 05/03/22 DermTech affirms FY22 assay revenue view of $22M-$26M 04/28/22 DermTech announces publication of new GvHD clinical research 03/08/22 DermTech says cost-benefit study published in Journal of Cutaneous Medicine DMTK DermTech $8.42 / -0.02 (-0.24%) 08:46 Today Craig-Hallum DermTech price target lowered to $18 from $37 at Craig-Hallum 07/18/22 Oppenheimer DermTech assumed with an Outperform at Oppenheimer 05/09/22 BTIG DermTech transferred with a Buy at BTIG 05/04/22 Cowen DermTech price target lowered to $20 from $33 at Cowen DMTK DermTech $8.42 / -0.02 (-0.24%) 08/08/22 DermTech reports Q2 EPS (99c), consensus ($1.01) 05/03/22 DermTech reports Q1 EPS ($1.01), consensus (89c) 03/01/22 DermTech sees FY22 revenue $22M-$26M, consensus $24.2M 03/01/22 DermTech sees Q1 revenue $3.4M-$3.8M, consensus $4.25M DMTK DermTech $8.42 / -0.02 (-0.24%) 08/08/22 Fly Intel: After-Hours Movers 04/30/22 Short Report: Gogo shorts reach altitude at one-year high as stock retreats

Hot Stocks	Aware appoints Herman as CRO » 09:15 08/09/22 08/09 09:15 08/09/22 09:15 AWRE Aware $2.22 / +0.15 (+7.25%) , CRM Salesforce $189.83 / -0.42 (-0.22%) Aware (AWRE) announced… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options AWRE CRM AWRE Aware $2.22 / +0.15 (+7.25%) 08/04/22 Aware to exhibit cybersecurity authentication solutions at Febraban conference 08/01/22 Aware bringing AwareABIS family of products to 2022 IAI Educational Conference 06/15/22 Aware to exhibit mobile authentication solutions at ID4Africa 2022 03/30/22 Aware supports Flutter Version 2.10 into Knomi platform CRM Salesforce $189.83 / -0.42 (-0.22%) 07/01/22 Salesforce CEO sells another $51.5M in common stock 06/29/22 Salesforce CEO sells $53M in common stock 06/09/22 Cloudflare announces Hawkins elected to board of directors 06/08/22 LiveRamp joins Salesforce AppExchange AWRE CRM AWRE Aware $2.22 / +0.15 (+7.25%) 09/13/21 Lake Street Aware initiated with a Buy at Lake Street CRM Salesforce $189.83 / -0.42 (-0.22%) 09:11 Today UBS UBS sees 'downtick' in partner tone ahead of Salesforce earnings 07/18/22 Piper Sandler Salesforce price target lowered to $220 from $250 at Piper Sandler 06/02/22 Loop Capital Salesforce price target lowered to $175 from $225 at Loop Capital 06/01/22 RBC Capital Salesforce margin outlook overshadowed lower revenue guide, says RBC Capital CRM CRM Salesforce $189.83 / -0.42 (-0.22%) 05/31/22 Salesforce jumps 5.5% to $169.12 after Q1 earnings beat 05/31/22 Salesforce cuts FY23 revenue view to $31.7B-$31.8B, consensus $32.06B 05/31/22 Salesforce sees Q2 revenue $7.69B-$7.70B, consensus $7.77B 05/31/22 Salesforce sees FY23 EPS $4.74-$4.76, consensus $4.65 CRM CRM Salesforce $189.83 / -0.42 (-0.22%) 08/04/22 Salesforce closes Hong Kong office, looks to Alibaba, TechCrunch reports 03/05/22 Cloud stocks have become a haven in tech, Barron's says CRM CRM Salesforce $189.83 / -0.42 (-0.22%) 06/01/22 What You Missed On Wall Street On Wednesday 06/01/22 What You Missed On Wall Street This Morning 06/01/22 Fly Intel: Pre-market Movers 05/31/22 Fly Intel: After-Hours Movers 08/24/22 Salesforce - CRM CRM CRM Salesforce $189.83 / -0.42 (-0.22%) 07/20/22 Early notable gainers among liquid option names on July 20th 07/12/22 Salesforce put volume heavy and directionally bearish 06/01/22 Early notable gainers among liquid option names on June 1st 05/31/22 Salesforce options imply 7.6% move in share price post-earnings
Hot Stocks	Rockley Photonics gets first commercial order for Rockley Bioptx band » 09:15 08/09/22 08/09 09:15 08/09/22 09:15 RKLY Rockley Photonics $2.04 / -0.235 (-10.33%) Rockley Photonics… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options RKLY Rockley Photonics $2.04 / -0.235 (-10.33%) 07/26/22 Rockley Photonics announces strategic partnership with contract research group 06/16/22 Rockley customer begins evaluation program using its sensing technology 06/15/22 Rockley Photonics CFO Mahesh Karanth to step down 06/13/22 Rockley Photonics set to join Russell 3000 Index RKLY Rockley Photonics $2.04 / -0.235 (-10.33%) 06/08/22 Baird to hold a conference 06/07/22 Baird to hold a conference 05/13/22 Needham Rockley Photonics price target lowered to $4 from $8 at Needham 03/09/22 Northland Rockley Photonics price target lowered to $10 from $20 at Northland RKLY Rockley Photonics $2.04 / -0.235 (-10.33%) 06/15/22 Rockley Photonics affirms FY22 revenue guidance 05/12/22 Rockley Photonics reports Q1 adjusted EPS (28c), consensus (25c) 03/08/22 Rockley Photonics sees FY22 revenue $20M-$30M, consensus $24.87M 03/08/22 Rockley Photonics reports Q4 adjusted EPS (6c), consensus (33c) RKLY Rockley Photonics $2.04 / -0.235 (-10.33%) 04/22/22 Rockley Photonics falls after Iceberg Research reveals short position 04/22/22 Iceberg Research announces short position in Rockley Photonics RKLY Rockley Photonics $2.04 / -0.235 (-10.33%) 04/22/22 What You Missed On Wall Street On Friday 04/22/22 What You Missed On Wall Street This Morning 03/08/22 Fly Intel: After-Hours Movers 08/11/22 Rockley Photonics - RKLY RKLY Rockley Photonics $2.04 / -0.235 (-10.33%) 06/22/22 Largest borrow rate increases among liquid names 05/12/22 Rockley Photonics Holdings options imply 14.2% move in share price post-earnings 03/08/22 Rockley Photonics Holdings options imply 13.6% move in share price post-earnings
General news	Treasury Action: yields are extending their cheapening bent » 09:15 08/09/22 08/09 09:15 08/09/22 09:15 $ECON Economic Data / + Treasury Action: yields… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly $ECON Economic Data / + 06/22/22 President Biden calls on Congress to suspend federal gas tax 05/19/22 Could crypto crash be good for U.S. economy? Probably. 05/12/22 Miller calls out Taylor Morrison, GM as names that may work in this environment 04/21/22 Powell says 50 basis point hike on table for May meeting $ECON Economic Data / + $ECON Economic Data / + 06/14/22 Ackman says 100 point hike tomorrow 'would be better' than 75 02/11/22 Gundlach sees five interest rate raises in 2022 $ECON Economic Data / + 07/26/22 Ackman says biggest risk to economy is inflation, not higher rates 06/17/22 White House, Congress in talks over bill to fight inflation, Bloomberg says 06/13/22 Fed more likely to consider 0.75 point hike given recent data, WSJ says 05/10/22 Tepper says covered Nasdaq short, CNBC reports $ECON Economic Data / + 07/27/22 What You Missed On Wall Street On Wednesday 07/21/22 What You Missed On Wall Street On Thursday 07/21/22 What You Missed On Wall Street This Morning 07/06/22 What You Missed On Wall Street On Wednesday
Earnings	Burford Capital reports 1H EPS (10c) vs. (13c) last year » 09:14 08/09/22 08/09 09:14 08/09/22 09:14 BUR Burford Capital $10.90 / +0.12 (+1.11%) Reports 1H revenue $106M… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events BUR Burford Capital $10.90 / +0.12 (+1.11%) 08:51 Today Burford Capital appoints Rukia Baruti as non-executive director 05/26/22 Burford Capital extends life of sovereign wealth fund arrangement 04/04/22 Burford Capital announces private offering of senior notes BUR Burford Capital $10.90 / +0.12 (+1.11%) 05/13/22 B. Riley Burford Capital initiated with a Buy at B. Riley 03/24/22 Peel Hunt Burford Capital upgraded to Buy from Add at Peel Hunt BUR Burford Capital $10.90 / +0.12 (+1.11%) 03/29/22 Burford Capital reports 2021 EPS (33c) vs. 75c last year 08/08/22 42nd Annual Global I Growth Conference
Recommendations	Trex Company price target lowered to $58 from $67 at DA Davidson » 09:14 08/09/22 08/09 09:14 08/09/22 09:14 TREX Trex Company $63.74 / -0.91 (-1.41%) DA Davidson analyst Kurt… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events TREX Trex Company $63.74 / -0.91 (-1.41%) 08/08/22 Trex Company falls 9% to $58.00 after Q2 results, below-consensus guidance 06/06/22 Trex Company provides railing solutions for University of Texas 05/16/22 Trex expands its decking line with introduction of Trex Transcend Lineage 04/28/22 Trex Company debuts Ocula, newest glass windscreen system TREX Trex Company $63.74 / -0.91 (-1.41%) 08:28 Today B. Riley Trex Company should be bought on earnings selloff, says B. Riley 08:00 Today Stifel Trex Company price target lowered to $68 from $77 at Stifel 07:41 Today Truist Trex Company price target lowered to $85 from $90 at Truist 05:49 Today Barclays Trex Company price target lowered to $53 from $63 at Barclays TREX Trex Company $63.74 / -0.91 (-1.41%) 08/08/22 Trex Company sees Q3 revenue $180M-$190M, consensus $355.0M 08/08/22 Trex Company reports Q2 EPS 79c, consensus 68c 05/09/22 Trex Company backs FY22 revenue growth view of double-digits, consensus $1.38B 05/09/22 Trex Company sees Q2 revenue $375M-$385M, consensus $376.52M TREX Trex Company $63.74 / -0.91 (-1.41%) 08/08/22 Fly Intel: After-Hours Movers 05/20/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/25/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 04/06/22 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 00:00 Today Jefferies Industrial Conerence

Events

Earnings calls, analyst events, roadshows and more

GCMG
Today at 10:00

GCM Grosvenor - GCMG Conference Calls
STXS
Today at 10:00

Stereotaxis - STXS Conference Calls
NOVT
Today at 10:00

Novanta - NOVT Conference Calls
NCLH
Today at 10:00

Norwegian Cruise Line - NCLH Conference Calls
SNCY
Today at 10:00

Sun Country Airlines - SNCY Conference Calls
PFG
Today at 10:00

Principal Financial - PFG Conference Calls
AFCG
Today at 10:00

AFC Gamma - AFCG Conference Calls
TSE
Today at 10:00

Trinseo - TSE Conference Calls
EDRY
Today at 10:00

EuroDry - EDRY Conference Calls
UWMC
Today at 10:00

UWM Holdings - UWMC Conference Calls

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	AYTU X AYTU Aytu BioPharma Spot Secondary Managers: Cantor Fitzgerald & Canaccord Priced at: $0.43 21.5M Shares BRBR X BRBR BellRing Brands Spot Secondary Managers: JPMorgan, Barclays, Citi, Goldman Sachs & Morgan Stanley Priced at: $23.50 14.8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MDNA X MDNA Medicenna Therapeutics Spot Secondary Managers: Guggenheim, Bloom Burton Securities Priced at: $1.50 13.333M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial NUZE X NUZE NuZee Spot Secondary Managers: Maxim Priced at: $0.82 4.2M Shares PFLT X PFLT PennantPark Floating Rate Spot Secondary Managers: Morgan Stanley, Goldman Sachs, JPMorgan, Keefe Bruyette, RBC Capital & Truist Priced at: $12.40 4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	No deals
Wed	No deals
Thurs	No deals
Fri	No deals

Mon	No deals
Tues	CINC X CINC CinCor Pharma Secondary Managers: Goldman Sachs, Morgan Stanley, Jefferies & Piper Sandler $35.00 6M Shares KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan, Jefferies $241.19 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	FRZA X FRZA Forza X1 IPO Managers: ThinkEquity $5.00 3M Shares PTLO X PTLO Portillo's Secondary Managers: Jefferies & Morgan Stanley, BofA, Piper Sandler $28.44 8M Shares SOVO X SOVO Sovos Brands Secondary Managers: JPMorgan & Goldman Sachs, BofA, Credit Suisse, Barclays, UBS, Cowen, Piper Sandler, Stifel, William Blair, Telsey Advisory, Drexel Hamilton, Loop Capital $16.01 8.5M Shares
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

Plum Acquisition Corp. I opens at $9.99, IPO priced at $10

OTHER BREAKING NEWS FROM THE FLY

Get Full Fly Access